Optimized Two-Photon Imaging by Stimuli-Responsive Peptide Self-Assembly Facilitates Self-Assisted Counteraction of Cisplatin-Resistance in Cancer Cells
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c00998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Jie Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Nanfang Hospital, Southern M…. Hauptthemen laut MEDLINE: Cisplatin, Peptides, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Science Fund for Distinguished Young Scholars, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Accurate diagnosis and effective treatment of tumors remain significant clinical challenges. While fluorescence imaging is essential for tumor detection, it has limitations in terms of specificity, penetration depth, and emission wavelength. Here, we report a novel glutathione (GSH)-responsive peptide self-assembly excimer probe (pSE) that optimizes two-photon tumor imaging and self-assisted counteraction of the cisplatin resistance in cancer cells. The GSH-responsive self-assembly of pSE induces a monomer-excimer transition of coumarin, promoting a near-infrared redshift of fluorescence emission under two-photon excitation. This process enhances penetration depth and minimizes interference from biological autofluorescence. Moreover, the intracellular self-assembly of pSE impacts GSH homeostasis, modulates relevant signaling pathways, and significantly reduces GSTP1 expression, resulting in decreased cisplatin efflux in cisplatin-resistant cancer cells. The proposed self-assembled excimer probe not only distinguishes cancer cells from normal cells but also enhances the efficacy of cisplatin chemotherapy, offering significant potential in tumor diagnosis and overcoming cisplatin-resistant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
- Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou 51028…
ORCID-Profile: Jie Zhan, Yanbin Cai, Zhimou Yang, Lei Zheng
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Science Fund for Distinguished Young Scholars
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
- Nanfang Hospital, Southern Medical University
Zitieren
APA
Zhan, J., Huang, J., Xiao, Q., Yu, Z. A., Wang, Y., Wang, X., Liu, F., Cai, Y., Yang, Z., & Zheng, L. (2024). Optimized Two-Photon Imaging by Stimuli-Responsive Peptide Self-Assembly Facilitates Self-Assisted Counteraction of Cisplatin-Resistance in Cancer Cells. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c00998
Vancouver
Zhan J, Huang J, Xiao Q, Yu ZA, Wang Y, Wang X, et al. Optimized Two-Photon Imaging by Stimuli-Responsive Peptide Self-Assembly Facilitates Self-Assisted Counteraction of Cisplatin-Resistance in Cancer Cells. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c00998
BibTeX
@article{Zhan2024,
author = {Zhan, Jie and Huang, Jinyan and Xiao, Qiuqun and Yu, Ze-An and Wang, Yenan and Wang, Xing and Liu, Fengjiao and Cai, Yanbin and Yang, Zhimou and Zheng, Lei},
title = {Optimized Two-Photon Imaging by Stimuli-Responsive Peptide Self-Assembly Facilitates Self-Assisted Counteraction of Cisplatin-Resistance in Cancer Cells},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c00998}
}
EUVIMED